sermorelin peptide vs bpc 157 What to know: the 4 peptides FDA just cleared bpc 157 peptide and sermorelin

Marques, Natlia Nunes, Bruno Paulo Rodrigues Lustosa, Daniel Wagner Castro Lima Santos, Flvio Queiroz-Telles, Sybren de Hoog, Renata R

If you have been managing a chronic soft tissue issue, GI inflammation that standard approaches have not resolved, or post-surgical recovery that is progressing slower than expected, a BPC-157 consultation at our Doral clinic starts with a full clinical intake, not a generic protocol handed off without context

The barrier will still be an investigational new drug application in an FDA designated disease indication (of which for many of these peptide use cases, there isn't one)

Common sites: lower abdomen (2 inches from the navel), upper thigh, or proximal to the target injury